about
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.Reproducibility of the WHO classification of thymomas: practical implicationsA phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma.Impact of pre-storage and bedside filtered leukocyte-depleted blood transfusions on infective morbidity after colorectal resection: a single-center analysis of 437 patients.Neuropsychological and behavioural aspects in children and adolescents with idiopathic epilepsy at diagnosis and after 12 months of treatment.Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.Influence of selected lifestyle factors on risk of acute myocardial infarction in subjects with familial predisposition for the disease.Diet diversity and the risk of oral and pharyngeal cancer.High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid.Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy.Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.Influence of selected hormonal and lifestyle factors on familial propensity to ovarian cancer.A post-marketing study on immunomodulating treatments for relapsing-remitting multiple sclerosis in Lombardia: preliminary results.The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer.Acute cholecystitis: the golden 72-h period is not a strict limit to perform early cholecystectomy. Results from 316 consecutive patients.Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability.Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy.Weekly non-pegylated liposomal doxorubicin chemotherapy in heavily pre-treated patients with metastatic breast cancer.Influenza vaccine in healthy children: a meta-analysisSorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisThymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/CarboplatinInter-rater reliability of the EEG reading in patients with childhood idiopathic epilepsyPhase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumorsPrimary headache and epilepsy: A multicenter cross-sectional studyRetreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesotheliomaAllogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphomaRight colon, left colon, and rectal surgeries are not similar for surgical site infection development. Analysis of 277 elective and urgent colorectal resectionsUnmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma
P50
Q35994860-4DABBCE9-C5FB-4C6E-ACD8-819808CB1B1AQ36617625-84001408-1523-4CF9-A0A3-E5331D243E04Q40224897-6D2A3D7F-5FAB-4DD8-A193-2413F976D087Q42254888-2E6E1B43-6C7D-491A-AC23-FD6BC6546DF8Q42928608-1C7B8864-82D4-46FC-B82B-77484D96B2C6Q43508188-88F1660A-FBA1-4F52-A390-9474A65B8310Q44343748-339F803F-E602-4A55-9031-DE2DE27827CBQ44799485-07CDEBF5-3F36-484D-B070-159044BF2BF3Q45839807-719C37D7-CDB8-487B-B554-58810F308271Q46027432-5532CBA1-78BF-433D-9711-F29300749FF9Q46054785-69FD4C42-2128-4B1D-84D0-3A9D4681CB88Q46062506-B2015F8D-126B-4D09-8F2A-15FC556EE36CQ46256306-1001BCD8-AEDD-4D9D-918B-99476DB0FED9Q46875585-68F90218-7527-48FC-8758-6345199D520CQ46893706-CFCB6B28-636A-4754-A278-1A0C0A54B100Q50168404-2589A618-C1FB-45D3-A8C9-5B533E3BA2DDQ50703278-1648A230-CB94-4BFD-97DB-1E809C5285EFQ50761266-4A57E7F1-B050-46E4-AE5F-799140162804Q53097045-600F1470-A282-4779-B831-925E8B48927EQ54445262-88A7014E-B020-4F8B-9A96-8E74EC9CB853Q54766465-FC3FDA17-F15C-4928-9C24-C3074A1DEE22Q57560041-2FB5457B-E8C6-49F4-A106-D05A9C597788Q57758019-701980FA-7620-4393-82B4-B3B13B72886BQ57890679-A6EBD8F3-03E0-4380-BB68-AE1691678E3CQ57898293-7448FC6A-2AE2-4158-B720-78C8D9B87C50Q57972640-BA1FD6D4-EEEF-4F07-AC38-5239C093803EQ59222755-C8055323-00E8-4121-9CB4-5FA2BAB496B6Q83153976-AF411225-FA46-4548-A7AE-4FA1121CAE97Q83474458-0058C810-DAE1-4721-841E-69F684BA21CFQ85158449-A5EB359A-E801-47FB-982D-FE8AC7D93DE5Q86636858-C5AABEFF-EE24-4B27-A80B-AEEBBA6CF2BF
P50
description
researcher
@en
հետազոտող
@hy
name
L Giordano
@ast
L Giordano
@en
L Giordano
@es
L Giordano
@nl
L Giordano
@sl
type
label
L Giordano
@ast
L Giordano
@en
L Giordano
@es
L Giordano
@nl
L Giordano
@sl
prefLabel
L Giordano
@ast
L Giordano
@en
L Giordano
@es
L Giordano
@nl
L Giordano
@sl
P106
P31
P496
0000-0002-9587-7870